Insmed (INSM) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $120.82 --0%
EPS Growth %: +77.7%
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +77.7%
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($0.96), $0.01 worse than the analyst estimate of ($0.95). Revenue for the quarter came in at $21.9 million versus the consensus estimate of $19.62 million.
The Company now expects full-year 2019 revenues for ARIKAYCE to be in the range of $90 million to $105 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- General Mills (GIS) Tops Q1 EPS by 3c
- Oppenheimer Starts Viatris (VTRS) at Outperform
- Goldman Sachs Downgrades Bank Mandiri (BMRI:IJ) (PPERF) to Sell, 'Liquidity and capital tightness'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
